CHICAGO — A one-time dose of a novel cell therapy appeared safe and produced months-long seizure control in patients with bilateral drug-resistant mesial temporal lobe epilepsy (MTLE), according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results